Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc

Kennewick, Washington 99336

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, PI3K Pathway Activated Tumors, Solid Tumor and Hematologic Malignancies, Tumors With CDK4/6 Pathway Activation

Studies at this site

• MEK162 for Patients With RAS/RAF/MEK Activated Tumors — Completed
• Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor — Completed
• LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) — Completed
• BKM120 for Patients With PI3K-activated Tumors — Completed